Indium (In111) Chloride Curium Netherlands (Indium (111in))

Indium-111 chloride is used in diagnostic imaging procedures targeting infection, inflammation and tumor detection.

• Infection and inflammation imaging: enables visualization of active infection or inflammatory sites by labeling autologous white blood cells for scintigraphy.
• Tumor imaging and localization: assists in detecting and delineating malignant lesions through targeted radiolabeling of tumor‑associated markers.
• Diagnostic scintigraphy: provides gamma emission for gamma‑camera imaging in various nuclear medicine studies.

• Indium-111 chloride emits gamma photons of 171 and 245 keV, which are detected by gamma cameras. When administered, the compound can be directly injected or used to label autologous leukocytes ex vivo. The labeled cells or molecules retain the radionuclide, allowing the distribution of the radiotracer to be visualized. The emitted gamma radiation enables high‑resolution planar or SPECT imaging of physiological processes associated with infection, inflammation or tumor activity.

Indium-111 chloride may be associated with adverse reactions following intravenous administration.

Common Side Effects

• Injection site pain: mild discomfort at the site of injection.
• Transient flushing: brief feeling of warmth or redness.
• Nausea: mild, self‑limiting nausea.
• Headache: occasional mild headache.

Serious or Rare Side Effects

• Allergic reaction (anaphylaxis): severe hypersensitivity requiring immediate treatment.
• Radiation‑induced leukopenia: reduction in white blood cell count after high cumulative exposure.
• Severe hypotension: marked drop in blood pressure following injection.
• Organ toxicity: rare injury to kidneys or liver due to radiation.

Prior to using Indium-111 chloride, several precautions should be observed to ensure patient safety and optimal imaging results.

• Pregnancy: use only when benefits outweigh potential fetal radiation risk.
• Breastfeeding: discontinue nursing or consider alternative imaging agents.
• Renal impairment: evaluate kidney function as excretion may be reduced.
• Concurrent radiopharmaceuticals: avoid overlapping studies within 24 hours to prevent excess radiation.
• Radiation safety: apply ALARA principles and protect staff with shielding.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Indium-111 chloride can interact with certain drugs or procedures that affect radiation exposure or hematologic status.

Major Interactions (Avoid)

• Concurrent high‑dose iodine therapy: may interfere with imaging interpretation.
• Other radiopharmaceuticals within 24 h: risk of cumulative radiation dose.
• Chemotherapeutic agents causing bone‑marrow suppression: increased risk of hematologic toxicity.

Moderate Interactions (Monitor Closely)

• Antihistamines: may mask mild allergic responses to the tracer.
• Beta‑blockers: could alter hemodynamic response during injection.
• Contrast media: may modify biodistribution of the radiotracer.